Using a mouse model of chronic headache induced by repetitive intraperitoneal injections of isosorbide dinitrate (ISDN), we demonstrated the association of therapeutic effects of systemic eCB application on headache and anxiety comorbidity with increased eCB signaling and subsequent activation of AI-PrL and AI-ovBNST circuits and counteraction. The gene discussed is PRL; the disease is Anxiety.